Recombinant I3 is a full-length (1–125 amino acids) protein derived from guinea pig brain tissue, expressed in E. coli and purified with an N-terminal His tag for affinity chromatography . Its UniProt identifier is Q99N46, and it shares >90% sequence identity with human, mouse, and rat homologs . Originally identified in murine brain tissue, I3 is now recognized for its broader roles in immune responses and cellular trafficking .
I3 is implicated in delayed-type hypersensitivity (DTH) reactions, a cell-mediated immune response. Its mRNA and protein are detected in spleen cells, macrophages, and skin-infiltrating cells but absent in thymic cells . This suggests a role in peripheral immune cell activation rather than T-cell development.
Surface Expression: Partial membrane localization, inferred from sequence motifs .
Intracellular Trafficking: GFP-tagged I3 exhibits particulate cytoplasmic localization, colocalizing with lysosomes and late endosomes. This aligns with conserved endosomal/lysosomal-targeting motifs in its sequence .
Tissue Expression: I3 mRNA is widely expressed in guinea pig tissues, including spleen, liver, and lung, despite its initial association with brain .
Protein Localization: GFP-I3 colocalizes with lysosomal markers, suggesting involvement in vesicular trafficking or granule secretion .
Functional Motifs: Endosomal/lysosomal-targeting motifs in I3’s sequence hint at roles in membrane remodeling or cargo sorting .
Exact Mechanism: How does I3 regulate trafficking between lysosomes, endosomes, and the plasma membrane?
Pathological Roles: Potential links to immune disorders or neurodegenerative diseases remain unexplored.
Creative Biomart. (2025). Recombinant Full Length Guinea Pig Brain Protein I3 (I3) Protein, His-Tagged.
Nakada-Tsukui et al. (2009). Characterization of a cDNA Encoding Guinea Pig I3 Associated with DTH. Zoological Science, 26(9).
Nakada-Tsukui et al. (2009). I3 Localization in Immune Cells. BioOne.
Nakada-Tsukui et al. (2009). Endosomal/Lysosomal Colocalization of I3. BioOne.
Sigma-Aldrich. (2025). BRI3 Gene Overview.
Proteintech. (2025). BRI3 Antibody (14591-1-AP).
Recombinant Guinea pig Brain protein I3 (I3) participates in tumor necrosis factor-alpha (TNF)-induced cell death. It may also be a target of Wnt/β-catenin signaling in the liver.
STRING: 10141.ENSCPOP00000020651
Guinea pig Brain protein I3 was initially identified as a gene expressed in mouse brain, but subsequent research has demonstrated that it is widely expressed in various guinea pig tissues and immune cells. The protein encodes a polypeptide of 125 amino acids, and its amino acid sequence shows over 90% identity to human, mouse, and rat I3 proteins . Despite its name suggesting brain-specific expression, I3 has been found in numerous tissues, including immune cells such as spleen cells and macrophages, but is notably low in thymic cells . This widespread distribution suggests that I3 may have broader physiological roles than initially anticipated.
Guinea pig Brain protein I3 demonstrates a complex subcellular distribution pattern. Research utilizing fluorescent tagging has revealed that part of the I3 protein localizes to the cell surface membrane, while a significant portion shows particulate localization in the cytoplasm . Specifically, fluorescent microscopy studies with green fluorescent protein (GFP)-tagged I3 have shown that the protein partly colocalizes with lysosomes and late endosomes . This dual localization pattern is consistent with the presence of typical endosomal/lysosomal-targeting motifs in the I3 protein sequence, suggesting it may shuttle between the plasma membrane and intracellular compartments as part of its functional role.
Validating antibodies against Guinea pig Brain protein I3 requires a multi-step approach:
Western blot analysis: Test the antibody against recombinant I3 protein and guinea pig tissue lysates (especially brain, spleen, and macrophage extracts) to confirm specificity based on molecular weight.
Immunocytochemistry: Perform immunostaining of cells known to express I3 (based on mRNA detection) and verify the expected subcellular localization patterns (membrane and cytoplasmic puncta colocalizing with endosomal/lysosomal markers).
Negative controls: Include thymic cells which show minimal I3 expression as negative controls in validation experiments .
Cross-reactivity assessment: Due to the high sequence homology (>90%) with human, mouse, and rat I3 proteins, evaluate potential cross-reactivity with these species, which may be advantageous for comparative studies.
Blocking peptides: Use specific peptide competition assays to confirm antibody specificity.
Based on current understanding of I3 expression and function, several experimental models can be considered:
Primary guinea pig cells: Macrophages and spleen cells show strong I3 expression and represent physiologically relevant models .
Brain-derived cell cultures: Given I3's original identification in brain tissue, primary neuronal cultures or brain slice preparations from guinea pigs would be appropriate for studying its neuronal functions.
Delayed-type hypersensitivity (DTH) model: Since I3 has been identified as a gene associated with the guinea pig skin DTH reaction, this immunological model provides a functional context for studying I3 .
Heterologous expression systems: Transfection of I3 constructs (wild-type or tagged versions) into cell lines with low endogenous expression allows for controlled functional studies and protein interaction analyses.
Subcellular fractionation: Given I3's localization in endosomal/lysosomal compartments, fractionation approaches can be used to study its distribution and trafficking dynamics.
RNA interference (RNAi) experiments to study I3 function require careful design considering several methodological aspects:
Target sequence selection: Design multiple siRNA sequences targeting different regions of the I3 mRNA, avoiding regions with high homology to other transcripts. Given the high conservation across species, examine alignment with related species' I3 sequences to identify guinea pig-specific regions.
Delivery methods:
For primary guinea pig macrophages, nucleofection or specialized transfection reagents designed for primary cells are recommended
For brain cells, consider lentiviral delivery systems which provide sustained expression and higher efficiency in neuronal cells
Controls:
Include non-targeting siRNA controls with similar GC content
Create rescue experiments with RNAi-resistant I3 constructs containing silent mutations in the target sequence
Validation of knockdown:
Measure I3 mRNA reduction by quantitative PCR
Confirm protein reduction via Western blot or immunofluorescence
For partial localization phenotypes, quantitative image analysis of the cytoplasmic particulate distribution versus membrane localization
Functional readouts:
Assessment of endosomal/lysosomal trafficking using pulse-chase experiments with fluorescent markers
Analysis of plasma membrane protein composition and turnover rates
Evaluation of immune cell functions in the context of DTH responses
Several complementary approaches are recommended for comprehensive analysis of I3 protein interactions:
Co-immunoprecipitation (Co-IP):
Use antibodies against endogenous I3 or epitope-tagged versions
Perform reciprocal Co-IPs to confirm interactions
Consider chemical crosslinking prior to cell lysis to capture transient interactions
Include appropriate controls including IgG controls and I3-negative cell lysates
Proximity labeling techniques:
BioID or TurboID fusion constructs with I3 to identify proteins in close proximity in living cells
APEX2-based proximity labeling for temporal control of labeling reactions
These approaches are particularly valuable for identifying interactions within endosomal/lysosomal compartments
Fluorescence-based interaction assays:
Förster Resonance Energy Transfer (FRET) between I3 and candidate interactors
Fluorescence Lifetime Imaging Microscopy (FLIM) for quantitative analysis
Bimolecular Fluorescence Complementation (BiFC) to visualize interactions in specific subcellular locations
Mass spectrometry-based interactomics:
Quantitative approaches comparing I3 immunoprecipitates with controls
Analysis under different cellular conditions (resting vs. stimulated)
Differential interactome analysis between wild-type I3 and mutants lacking specific domains or motifs
Yeast two-hybrid screening:
Consider membrane yeast two-hybrid systems given I3's membrane association
Split-ubiquitin systems may be particularly suitable for membrane-associated proteins
Given I3's localization to endosomal/lysosomal compartments, the following methodological approaches are recommended:
Live-cell imaging of labeled I3:
Generate fluorescent protein fusions maintaining proper targeting motifs
Perform time-lapse microscopy to track I3-positive vesicles
Use photoactivatable or photoswitchable fluorescent proteins to follow specific vesicle populations
Colocalization studies:
Quantitative colocalization analysis with established markers of the endocytic pathway
Multiple markers should be used including Rab5 (early endosomes), Rab7 (late endosomes), LAMP1 (lysosomes)
Super-resolution microscopy techniques can provide detailed spatial relationships
Cargo trafficking assays:
Monitor internalization and degradation of model cargoes (e.g., transferrin, EGF, dextran)
Pulse-chase experiments with fluorescently labeled or biotinylated cargoes
Quantify kinetics of internalization, recycling, and degradation in cells with normal or altered I3 levels
pH-sensitive probes:
Use ratiometric pH sensors to measure vesicular pH in I3-positive compartments
Monitor pH changes during vesicle maturation and trafficking
Dominant-negative approach:
Express I3 mutants lacking specific functional domains or with mutated targeting motifs
Analyze their effects on endosomal morphology and function
A comprehensive workflow for identifying post-translational modifications (PTMs) of I3 includes:
In silico prediction:
Use bioinformatic tools to predict potential phosphorylation, glycosylation, ubiquitination, and other modification sites
Compare predictions across species given the high conservation of I3 sequence
Enrichment strategies:
Immunoprecipitation of I3 from different cellular compartments
Phosphoprotein enrichment using TiO₂ or IMAC for phosphorylation studies
Lectin affinity chromatography for glycosylation analysis
Di-Gly remnant antibodies for ubiquitination sites
Mass spectrometry analysis:
Use multiple proteases to increase sequence coverage
Employ fragmentation methods optimized for PTM analysis (ECD, ETD, HCD)
Consider top-down proteomics approaches for intact protein analysis
Targeted MS approaches (PRM, MRM) for quantitative analysis of specific modifications
Functional validation:
Generate site-specific mutants (phospho-null, phospho-mimetic)
Compare localization, stability, and interaction profiles of wild-type and mutant proteins
Assess the effect of specific PTM-inducing conditions (e.g., cellular stress, immune activation)
Dynamic PTM profiling:
Analyze temporal changes in PTMs during cellular processes
Compare PTM profiles across different tissues and cell types
Evaluate the interplay between different types of modifications
When designing expression constructs for recombinant I3, several factors should be considered:
Vector selection:
For mammalian expression, vectors with CMV or EF1α promoters typically yield good expression
For bacterial expression, consider fusion partners (such as MBP, GST, or SUMO) to improve solubility
For structural studies, lentiviral vectors may provide more physiological expression levels
Tagging strategies:
C-terminal tags are generally preferred as they avoid disrupting N-terminal targeting sequences
For endosomal/lysosomal proteins like I3, verify that tags do not interfere with targeting motifs
Consider small epitope tags (FLAG, HA, V5) for applications where protein size matters
For localization studies, fluorescent protein fusions should be tested against antibody detection to confirm normal localization
Codon optimization:
For heterologous expression, codon optimization may improve yields
For mammalian expression of guinea pig I3, consider human-optimized codons given the high sequence similarity
Purification considerations:
Include a TEV or PreScission protease cleavage site if tag removal is desired
For membrane-associated proteins like I3, include detergent screening in purification optimization
Sequence verification:
Complete sequencing of the final construct is essential
Confirm the sequence against guinea pig genomic sequence (http://www.ncbi.nlm.nih.gov/nuccore/DS562855.1)
Several technical challenges may be encountered when studying I3:
Cross-reactivity issues:
Due to high sequence conservation, antibodies may cross-react with human or rodent I3
Solution: Use knockout or knockdown controls to verify antibody specificity
Validate antibodies with recombinant proteins from multiple species
Subcellular fractionation artifacts:
I3's dual localization (membrane and vesicular) can complicate fractionation analysis
Solution: Use multiple fractionation methods and verify with microscopy
Include markers for plasma membrane, endosomes, and lysosomes in all analyses
Expression level artifacts:
Overexpression may disrupt normal localization and function
Solution: Use inducible expression systems to titrate expression levels
Compare with endogenous protein expression patterns
Guinea pig-specific technical limitations:
Fewer genetic tools available compared to mouse or human research
Solution: Adapt techniques from related species
Consider developing species-specific tools when critical
Functional redundancy:
I3 may have functional redundancy with related proteins
Solution: Consider combinatorial knockdown approaches
Perform comparative studies across multiple cell types with different expression profiles
When facing contradictory results in I3 research, a systematic approach is recommended:
Cell type differences:
I3 functions may vary across cell types
Solution: Thoroughly characterize expression levels and localization patterns in each model system
Document cell culture conditions in detail, including passage number and cell density
Methodological variations:
Different detection methods may yield apparently contradictory results
Solution: Apply multiple independent techniques to validate key findings
Consider the limitations of each method (sensitivity, specificity, resolution)
Data analysis approaches:
Different analysis methods can lead to divergent interpretations
Solution: Use standardized analysis pipelines
Share raw data and analysis code when publishing
Protein interaction context:
Interactions and functions may be context-dependent
Solution: Carefully control cellular state (e.g., confluence, activation status)
Characterize temporal dynamics rather than single time points
Systematic validation framework:
Develop a validation hierarchy with multiple levels of evidence
Combine in vitro and cellular approaches
When possible, validate in primary cells and tissues
CRISPR-Cas9 approaches offer powerful tools for studying I3:
Genome editing strategies:
Design multiple gRNAs targeting exons of the I3 gene
For guinea pig cells, consider using species-specific optimization of CRISPR components
HDR templates should include 800-1000bp homology arms for efficient knock-in
Functional domain analysis:
Generate precise deletions or mutations of targeting motifs
Create domain swaps to investigate functional conservation across species
Engineer reporter knock-ins at the endogenous locus
Delivery considerations:
For primary guinea pig cells, nucleofection of ribonucleoprotein complexes often provides optimal efficiency
For in vivo applications, AAV-delivered CRISPR systems may be considered
Testing multiple delivery methods is essential for optimization
Screening considerations:
Design PCR-based screening strategies for edited clones
Include restriction sites in HDR templates to facilitate screening
Confirm edits by sequencing and protein expression analysis
Off-target analysis:
Perform whole-genome sequencing of edited cell lines to identify potential off-target effects
Use multiple independent clones for functional studies to control for clonal variation
Several cutting-edge technologies hold promise for advancing I3 research:
Cryo-electron microscopy:
Structural determination of I3 in membrane or vesicular contexts
Visualization of I3-containing protein complexes
Analysis of conformational states during trafficking processes
Proteomics approaches:
Proximity-dependent biotin identification (BioID) to map the spatial environment of I3
Thermal proteome profiling to identify I3 interactors and substrates
Crosslinking mass spectrometry to capture transient interactions
Advanced imaging techniques:
Lattice light-sheet microscopy for long-term imaging with minimal phototoxicity
Super-resolution microscopy (STORM, PALM, STED) for detailed localization studies
Correlative light and electron microscopy (CLEM) to connect functional imaging with ultrastructural analysis
Single-cell analysis:
Single-cell proteomics to examine I3 expression heterogeneity
Spatial transcriptomics to map I3 expression in complex tissues
Live-cell single-molecule tracking to follow individual I3 molecules
Organoid technologies:
Brain organoids to study I3 in a more physiological neural environment
Immune organoids to investigate I3's role in immune cell development and function
Multi-organ systems to examine tissue-specific functions
Computational methods offer valuable complementary approaches to experimental studies:
Protein structure prediction:
Use AlphaFold2 or RoseTTAFold to generate structural models of I3
Molecular dynamics simulations to investigate conformational dynamics
Predict interaction interfaces and binding pockets
Network analysis:
Integrate proteomic and transcriptomic data to place I3 in functional networks
Compare networks across species to identify conserved modules
Predict functional relationships based on co-expression patterns
Machine learning applications:
Develop predictive models for I3 localization based on sequence features
Automated image analysis for high-throughput phenotyping
Mining literature and databases for hidden relationships
Systems biology approaches:
Mathematical modeling of I3-dependent trafficking pathways
Sensitivity analysis to identify critical parameters in I3 function
Integration of multiple data types for comprehensive understanding
Evolutionary analysis:
Comparative genomics to identify conserved functional elements
Positive selection analysis to highlight functionally important residues
Reconstruction of ancestral sequences to understand functional evolution